Literature DB >> 7707810

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

M den Heijer1, H J Blom, W B Gerrits, F R Rosendaal, H L Haak, P W Wijermans, G M Bos.   

Abstract

Several studies have shown a relation between hyperhomocysteinaemia and arterial vascular disease. We looked at the association between hyperhomocysteinaemia and venous thrombosis which could be clinically important as hyperhomocysteinaemia is easily corrected by vitamin supplementation. We studied 185 patients with a history of recurrent venous thrombosis and 220 controls from the general population. Homocysteine concentrations were measured before and 6 h after oral methionine loading. We defined hyperhomocysteinaemia as the homocysteine concentration above the fasting or the postmethionine value found for the 90th percentile of the controls. Of the 185 patients with recurrent thrombosis, 46 (25%) had fasting homocysteine concentrations above the 90th percentile or the controls (odds ratio is 3.1 [1.8-5.5]). After adjustment for age, sex, and menopausal status the odds ratio was 2.0 (1.5-2.7). Similar results were found for the post-methionine value (unadjusted odds ratio 3.1 [1.7-5.5], adjusted 2.6 [1.9-3.5]). Hyperhomocysteinaemia is a common risk factor for recurrent venous thrombosis and can lead to a two-fold or three-fold increase in risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7707810     DOI: 10.1016/s0140-6736(95)90008-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Nutritional hyperhomocysteinaemia.

Authors:  I V Mohan; G Stansby
Journal:  BMJ       Date:  1999-06-12

Review 2.  Diagnosis and management of inherited and acquired thrombophilias.

Authors:  F A Spencer; R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

Review 3.  Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.

Authors:  A L Buchman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 4.  Thrombophilia: a genetic predisposition to thrombosis.

Authors:  R A Sacher
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

5.  Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis.

Authors:  P A Isotalo; J G Donnelly
Journal:  Mol Diagn       Date:  2000-03

6.  A cross-sectional study to detect the prevalence of hyperhomocysteinemia in cases of deep vein thrombosis.

Authors:  Gautam V Kamat; S C Metgud; Vishwanath M Pattanshetti; A S Godhi
Journal:  Indian J Surg       Date:  2010-11-19       Impact factor: 0.656

Review 7.  Hyperhomocysteinaemia and associated disease.

Authors:  R C Bakker; D P Brandjes
Journal:  Pharm World Sci       Date:  1997-06

Review 8.  Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation.

Authors:  Geoffrey D Barnes; Yogendra Kanthi; James B Froehlich
Journal:  Vasc Med       Date:  2015-04       Impact factor: 3.239

Review 9.  Genetics and pulmonary medicine. 4. Pulmonary embolism.

Authors:  M Laffan
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

10.  Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia.

Authors:  Bas Oldenburg; Bas A C Van Tuyl; René van der Griend; Rob Fijnheer; Gerard P van Berge Henegouwen
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.